Table of Contents
Company Snapshot 2
Table of Contents 5
GlaxoSmithKline Plc: Company Overview 9
GlaxoSmithKline Plc: Overview and Key Facts 9
GlaxoSmithKline Plc: Overview 9
GlaxoSmithKline Plc: Key Facts 9
GlaxoSmithKline Plc: Key Employees 11
GlaxoSmithKline Plc: Key Employee Biographies 13
GlaxoSmithKline Plc: Major Products and Services 20
GlaxoSmithKline Plc: Company History 22
GlaxoSmithKline Plc: Management Statement 37
GlaxoSmithKline Plc: Locations and Subsidiaries 39
GlaxoSmithKline Plc: Key Competitors 41
GlaxoSmithKline Plc: Company Analysis 42
GlaxoSmithKline Plc: Business Description 42
GlaxoSmithKline Plc: SWOT Analysis 44
GlaxoSmithKline Plc: SWOT Overview 44
GlaxoSmithKline Plc: Strengths 44
GlaxoSmithKline Plc: Weaknesses 45
GlaxoSmithKline Plc: Opportunities 46
GlaxoSmithKline Plc: Threats 47
GlaxoSmithKline Plc: Corporate Financial Deals Activity 49
GlaxoSmithKline Plc: Financial Deals Overview 49
GlaxoSmithKline Plc: Targets and Partners 51
GlaxoSmithKline Plc: Top Deals 2014 – 2018YTD* 54
GlaxoSmithKline Plc: Advisors 55
GlaxoSmithKline Plc: Top Legal Advisors 55
GlaxoSmithKline Plc: Top Financial Advisors 55
GlaxoSmithKline Plc: Mergers and Acquisitions 57
GlaxoSmithKline Plc: Corporate Venturing 58
GlaxoSmithKline Plc: Capital Raising 59
GlaxoSmithKline Plc: Partnership 60
GlaxoSmithKline Plc: Divestments 61
GlaxoSmithKline Plc: Recent Developments 62
GlaxoSmithKline Plc: News and Events Summary 62
GlaxoSmithKline Plc: Business Expansion 66
GlaxoSmithKline Plc: Business Reorganization 66
GlaxoSmithKline Plc: Contracts 67
GlaxoSmithKline Plc: Financial Deals 67
GlaxoSmithKline Plc: Financial Performance 68
GlaxoSmithKline Plc: Market Developments 68
GlaxoSmithKline Plc: Red Flags/DistressSignals 69
GlaxoSmithKline Plc: Regulatory and Legal Events 69
GlaxoSmithKline Plc: Strategy and Operations 70
Appendix 71
Contact Us 71
Methodology 71
About MarketLine 72
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 3: GlaxoSmithKline Plc: Locations and Subsidiaries
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 7: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 9: GlaxoSmithKline Plc: Targets and Partners
Table 10: GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD*
Table 11: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 12: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)
Table 23: GlaxoSmithKline Plc: News and Events Summary
Table 24: GlaxoSmithKline Plc: Business Expansion
Table 25: GlaxoSmithKline Plc: Business Reorganization
Table 26: GlaxoSmithKline Plc: Contracts
Table 27: GlaxoSmithKline Plc: Financial Deals
Table 28: GlaxoSmithKline Plc: Financial Performance
Table 29: GlaxoSmithKline Plc: Market Developments
Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals
Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 32: GlaxoSmithKline Plc: Strategy and Operations
List of Figures
Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)